Risk assessment is a critical aspect of the task force's work. The unique properties of nanomaterials, such as their size, shape, and surface characteristics, can pose different risks compared to conventional materials. The task force employs a multidisciplinary approach, leveraging expertise in toxicology, chemistry, and pharmacology to evaluate potential hazards and exposures.
